RENAISSANCE TECHNOLOGIES LLC
Position in KPTI — Karyopharm Therapeutics Inc.
CIK 1037389
NEW YORK, NY
Position in KPTI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,057,250
+$470,095 QoQ
Shares Held
108,214
+2.7% QoQ
Ownership
0.477%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 96 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KPTI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. KPTI ranks #177 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in KPTI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,057,250 | 108,214 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $587,155 | 105,414 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $440,967 | 59,914 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $423,229 | 64,714 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $283,658 | 65,814 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $228,940 | 61,214 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $812,950 | 1,202,590 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,030,367 | 1,241,407 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $656,405 | 756,227 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,369,268 | 906,800 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,699,186 | 1,964,377 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $978,736 | 730,400 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,194,646 | 667,400 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,861,873 | 735,700 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $643,620 | 189,300 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,683,318 | 308,300 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,051,148 | 454,800 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,585,287 | 215,100 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $552,337 | 85,900 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,883,228 | 495,400 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $190,631 | 18,472 | Shares | Sole | 2021-08-13 | |
| 2020-06-30 | $3,443,292 | 181,800 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $10,258,140 | 534,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||